We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Information for manufacturers of medical devices about reporting adverse incidents and field safety corrective actions to the MHRA.
Guidance for people with symptoms of a respiratory infection including COVID-19, or a positive test result for COVID-19.
Using metadata to make it easier to catalogue, validate, reuse and share your data.
Licence and registration application information for companies that deal in precursor chemicals.
Guide to licensing procedure and other restrictions for export of controlled dual-use items, software and technology, goods for torture and radioactive sources.
How to use an ethnographic study to evaluate your digital health product.
A wholesale dealer in Great Britain may import Qualified Person certified medicines from the European Economic Area if certain checks are made by the ‘Responsible Person (import)’
Guidance for completing forms ID1: Certificate of identity for a private individual, and ID2: Certificate of identity for a body corporate.
An overview of the work the IPO is undertaking in relation to Standard Essential Patents.
How to use a quasi-experimental study to evaluate your digital health product.
UK Health Security Agency's laboratories provide a comprehensive range of microbiological tests and services.
Using an ecological momentary assessment to evaluate your digital health product.
The epidemiology, symptoms, diagnosis and management of severe fever with thrombocytopaenia syndrome (SFTS).
When tests to detect COVID-19 are commonly used (use cases) and what to consider when deciding which type of test to employ.
A collection of factsheets, updated guidelines and news stories related to DBS and coronavirus.
For the notification of diagnosis of cases not identified through screening, this form covers the 6 inherited metabolic diseases (IMDs).
Frequently asked questions on the Levelling Up Fund Round 2.
Guidance for industry on flexible approaches we are taking on good distribution practices.
This guidance provides information on COVID-19 in homelessness, domestic abuse refuge, respite room and asylum seeker accommodation settings.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).